ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag survey ecology disease medicine immunology

bacteria and DNA molecules on a purple background.
Engineering the Microbiome: CRISPR Leads the Way
Mariella Bodemeier Loayza Careaga, PhD | Mar 15, 2024 | 10+ min read
Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.
Mining Bacterial Small Molecules
L. Caetano M. Antunes, Julian E. Davies and B. Brett Finlay | Jan 1, 2011 | 10 min read
As much as rainforests or deep-sea vents, the human gut holds rich stores of microbial chemicals that should be mined for their pharmacological potential.
Lurking in the Shadows
Bob Grant | Dec 1, 2014 | 10+ min read
Bats harbor diverse pathogens, including Ebola, Marburg, SARS, and MERS viruses. Understanding why could help researchers stymie deadly emerging diseases.
black lab mice microbiome
Microbes May Take Some of the Blame for the Reproducibility Crisis
Emma Yasinski | Apr 5, 2019 | 4 min read
Scientists find varied microbiota among the same strain of mice from four vendors—and that variability affects their susceptibility to infection.
Roll-Your-Own Microarrays
Jim Kling | Jan 6, 2002 | 3 min read
CDNA microarrays hold great promise for characterizing disease and performing genetic studies, but they're not exactly an out-of-the-box technology just yet. Often the scientists must prepare their own chips. Yet, this process is limited by the amount of space on the array itself—forcing researchers to make choices about which genes to include in their sample. Clinical microarray applications are further limited by the availability of sufficient cell numbers for testing purposes. Illumina
Molecular Multitasking
Carina Storrs | Aug 1, 2013 | 6 min read
Commercial kits use fluorescent beads to probe dozens of cytokines in one reaction.
Scientists at the Summit
Bob Calandra | Dec 1, 2003 | 7 min read
Courtesy of University of Texas M.D. Anderson Cancer Center Roy Herbst In those rare moments when Roy Herbst isn't seeing a patient or assessing the results of his research, he's aware of the quickening pace of time. So much of his time has been absorbed with education, training, mulling choices, and making hard decisions, each with potential to twist his life in a new direction. Somewhere in between the classes, the residency, the research, and the promotions, 22 years have slipped by.
Pasteur at 100: Echoes of Past, Future Promise
Alexander Dorozynski | Oct 4, 1987 | 4 min read
PARIS—The Pasteur Institute, which over the past century has evolved into a major center of biomedical research, celebrate its centennial this week with unusual panache for such a venerable institution. It enters its second century in far better financial shape than it was a decade ago, and having recently tucked several new feathers into its cap. French President Francois Mitterand and Prime Minister Jacques Chirac will launch the anniversary events, which include a conference on the f
60 Members Elected to NAS
Barry Palevitz | Jun 25, 2000 | 6 min read
Editor's Note: On May 2, the National Academy of Sciences announced the election of 60 new members and 15 foreign associates from nine countries in recognition of their distinguished and continuing achievements in original research. Nearly half of the new members are life scientists. In this article, The Scientist presents photographs of some of the new members and comments from a few of them on their careers and on past and current research. A full directory of NAS members can be found online a
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,

Run a Search

ADVERTISEMENT